This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Social disorders starting during childhood or adolescence
KRA_PSY_CHILDSOC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
318 |
4. Check minimum number of eventsNone |
318 |
5. Include endpointsNone |
318 |
6. Filter based on genotype QC (FinnGen only) |
291 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F90-F98
- Name in latin
- Perturbationes functionum socialium specialiter in pueritia incipientes
Similar endpoints
↥List of similar endpoints to
Social disorders starting during childhood or adolescence
based on the number of shared cases.
Similar with more cases:
- Social disorders starting during childhood or adolecense, excluding more controls
- Emotional disorders and disorders of social functioning with onset specific to childhood
- Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 291 | 165 | 126 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 11.39 | 12.33 | 10.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 318
- Matched controls
- 3180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F94.0
ICD-10 Finland
Elective mutism
+∞
100.5
91
*
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
+∞
78.4
72
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
+∞
75.0
69
*
F94.1
ICD-10 Finland
Reactive attachment disorder of childhood
+∞
61.5
57
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
8.7
53.6
79
117
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.4
48.4
144
421
N05AX08
ATC
risperidone; systemic
7.5
46.0
76
127
3138X
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[MUU MÄÄRITTELTY EMOTIONAALISENA OIREENA ILM. HÄIRIÖ]
+∞
46.0
43
*
N05AH03
ATC
olanzapine; systemic
7.1
45.8
82
149
Z2445
NOMESCO Finland
Psychologist
5.6
35.9
83
190
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.1
35.5
71
142
N05AH04
ATC
quetiapine; oral
4.3
35.2
136
469
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.1
35.1
59
99
N05AX12
ATC
aripiprazole; systemic
6.3
33.3
64
123
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.9
32.8
49
72
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.4
32.6
61
114
Z2446
NOMESCO Finland
Social worker
4.9
30.8
83
215
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
6.6
30.6
54
95
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.1
30.5
44
62
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.1
29.5
112
375
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.1
28.8
47
76
N05BA01
ATC
diazepam; systemic, rectal
5.2
27.1
63
143
ZY010
NOMESCO Finland
Hospital outpatient
4.8
26.6
71
181
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.9
26.6
67
163
F84.5
ICD-10 Finland
Asperger syndrome
10.6
26.3
30
31
R5599
NOMESCO Finland
Other rehabilitation service
8.2
25.6
36
49
N03AG01
ATC
valproic acid; systemic, rectal
5.7
24.9
51
103
N05AH02
ATC
clozapine; systemic
8.7
24.7
33
42
N06AB03
ATC
fluoxetine; oral
4.4
24.7
73
201
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
34.2
24.2
31
10
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
22.2
23.6
34
17
N05AA02
ATC
levomepromazine; systemic
8.1
23.4
33
45
ZYC01
NOMESCO Finland
Remote contact by phone
5.2
23.2
53
118
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.6
22.9
62
159
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.8
22.4
37
60
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
8.8
22.1
29
36
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.9
20.3
49
114
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.1
20.1
37
67
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.0
19.9
47
107
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.6
19.4
51
127
Z3231
NOMESCO Finland
Registered nurse
3.0
19.3
134
627
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
30.0
19.0
25
9
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.6
18.8
49
121
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.5
18.5
76
260
IGV01
NOMESCO Finland
Psychiatric network contact
6.4
18.3
32
55
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
18.1
48
120
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.1
17.6
54
151
N05AF03
ATC
chlorprothixene; systemic
14.4
17.3
29
22
N06AX16
ATC
venlafaxine; oral
3.4
17.1
72
250
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.0
17.0
53
150
F94.2
ICD-10 Finland
Disinhibited attachment disorder of childhood
+∞
16.8
16
*
IGP01
NOMESCO Finland
Psychiatric family contact
5.1
16.6
37
80
N05CF01
ATC
zopiclone; oral
3.4
16.6
70
243
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.9
16.0
30
55
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.1
16.0
25
38
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.0
15.8
36
79
N05BA04
ATC
oxazepam; oral
2.9
15.8
94
398
F92.0
ICD-10 Finland
Depressive conduct disorder
20.6
15.8
23
12
N06AB04
ATC
citalopram; systemic
3.5
15.7
61
200
N03AX09
ATC
lamotrigine; oral
4.4
15.6
42
106
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.3
15.5
43
111
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.4
15.5
23
33
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
4.8
15.4
37
85
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
15.4
45
121
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.4
15.1
31
62
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.9
15.1
28
51
F83
ICD-10 Finland
Mixed specific developmental disorders
6.5
14.9
25
41
Z61.8
ICD-10 Finland
Other negative life events in childhood
22.4
14.9
21
10
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.7
14.7
52
160
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
14.6
65
232
Z2221
NOMESCO Finland
Medical doctor
2.7
14.4
110
528
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.2
14.1
30
62
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.8
14.1
46
134
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.2
13.9
40
106
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
6.1
13.9
25
44
N06AB06
ATC
sertraline; oral
3.0
13.8
74
294
Z3226
NOMESCO Finland
Physiotherapist
2.8
13.5
84
361
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
13.3
71
281
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.9
13.1
30
66
F80.1
ICD-10 Finland
Expressive language disorder
6.0
13.1
24
43
P74
ICPC
Anxiety disorder/anxiety state
3.4
12.9
52
174
N06BA04
ATC
methylphenidate; oral
3.0
12.1
62
239
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.0
12.0
36
98
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
12.0
47
154
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
12.0
68
277
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
10.7
11.7
22
22
N06AX11
ATC
mirtazapine; oral
2.4
11.3
102
520
F80.2
ICD-10 Finland
Receptive language disorder
9.1
11.2
23
27
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.8
10.9
35
100
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.3
10.9
44
147
N06AB05
ATC
paroxetine; oral
4.6
10.5
26
61
Z61.1
ICD-10 Finland
Removal from home in childhood
113.6
10.5
11
*
3138C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[LAPSUUSIÄN RAJATILAHÄIRIÖ]
+∞
10.5
10
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.0
10.4
23
49
P99
ICPC
Psychological disorders other
4.4
10.4
27
66
N05BA06
ATC
lorazepam; systemic, sublingual
8.4
10.3
22
28
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
10.3
48
175
ZY000
NOMESCO Finland
Hospital inpatient
5.5
10.2
20
38
N06AX12
ATC
bupropion; oral
2.9
10.0
51
195
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.4
10.0
87
434
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.4
9.9
38
123
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
9.7
37
119
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.0
9.7
21
44
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
9.5
9.7
19
21
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.8
9.6
52
205
K59.09
ICD-10 Finland
Constipation, unspecified
4.4
9.6
25
61
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
15.7
9.6
15
10
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
9.6
54
218
N03AE01
ATC
clonazepam; systemic
4.7
9.5
22
49
N05BE01
ATC
buspirone; oral
8.1
9.3
20
26
F84.8
ICD-10 Finland
Other pervasive developmental disorders
14.2
9.3
15
11
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.8
9.2
21
46
N07BB01
ATC
disulfiram; oral
5.1
9.0
19
39
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
9.9
8.9
17
18
P29
ICPC
Psychological sympt/compl other
2.5
8.9
64
292
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
8.0
8.8
19
25
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.0
8.8
19
25
A28
ICPC
Limited function/disability NOS
3.7
8.7
29
85
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.6
99
550
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.6
8.4
28
82
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.4
8.4
19
27
P72
ICPC
Schizophrenia
7.4
8.4
19
27
3132C
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Sensitivity, shyness and social withdrawal disorder
+∞
8.4
8
*
A06AD11
ATC
lactulose; oral
3.4
8.3
31
98
S29
ICPC
Skin symptom/complaint other
2.3
8.2
76
386
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.5
8.2
29
89
N06AB10
ATC
escitalopram; oral
2.1
8.1
96
538
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.2
8.0
32
106
T74.1
ICD-10 Finland
Physical abuse
4.3
7.9
21
52
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
7.9
110
655
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.8
57
260
K59.0
ICD-10 Finland
Constipation
4.1
7.8
22
57
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
7.8
38
141
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
7.8
43
171
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
7.8
63
302
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
12.3
7.6
13
11
R4140
NOMESCO Finland
Psychotherapy
10.4
7.6
14
14
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
81.9
7.4
8
*
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
13.8
7.4
12
9
N03AX11
ATC
topiramate; oral
4.3
7.4
19
46
D11
ICPC
Diarrhoea
2.3
7.4
67
337
F88
ICD-10 Finland
Other disorders of psychological development
9.7
7.4
14
15
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.5
7.4
18
29
N06AX22
ATC
agomelatine; oral
6.5
7.4
18
29
L17
ICPC
Foot/toe symptom/complaint
2.0
7.3
104
621
N05CD07
ATC
temazepam; oral
7.6
7.3
16
22
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.6
7.3
16
22
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
4.1
7.3
20
51
K02.1
ICD-10 Finland
Caries of dentine
2.0
7.3
233
1824
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
7.1
31
108
IEP03
NOMESCO Finland
Focused parental counselling
4.4
7.1
18
43
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.2
7.0
67
343
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.9
95
558
ZXE00
NOMESCO Finland
One hour or less
1.9
6.9
128
832
ZXY03
NOMESCO Finland
Occupational therapist
14.2
6.9
11
8
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
14.2
6.9
11
8
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
6.9
67
345
AA1AD
NOMESCO Finland
CT of head and brain
2.5
6.9
46
201
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
7.0
6.9
16
24
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.4
6.9
17
28
N05AD01
ATC
haloperidol; systemic
9.6
6.8
13
14
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
9.6
6.8
13
14
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.7
6.8
22
63
R4120
NOMESCO Finland
Occupational therapy
3.2
6.8
28
94
C07AB07
ATC
bisoprolol; oral
2.3
6.8
58
284
Z61.9
ICD-10 Finland
Negative life event in childhood, unspecified
23.1
6.7
9
*
R11
ICD-10 Finland
Nausea and vomiting
2.5
6.6
45
199
N04AA02
ATC
biperiden; systemic
10.3
6.6
12
12
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.1
6.5
18
46
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.1
6.5
28
97
SPAT1240
SPAT
Therapeutic discussion
2.2
6.5
64
332
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.9
6.5
19
51
P76
ICPC
Depressive disorder
2.5
6.4
43
188
F21
ICD-10 Finland
Schizotypal disorder
14.7
6.4
10
7
RS214, ,
NOMESCO Finland
14.7
6.4
10
7
N05AN01
ATC
lithium; oral
4.0
6.4
18
47
AA400
NOMESCO Finland
Electroconvulsive therapy
11.3
6.3
11
10
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
9.5
6.3
12
13
Z71.8
ICD-10 Finland
Other specified counselling
1.8
6.3
129
860
N05AB03
ATC
perphenazine; systemic, rectal
5.2
6.3
18
36
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
+∞
6.3
6
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.6
6.2
17
32
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.0
6.2
16
28
N03AX16
ATC
[U] pregabalin
2.5
6.2
39
166
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.6
6.1
20
58
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
6.9
6.1
14
21
SPAT1260
SPAT
Consultation of another employee
2.2
6.0
58
297
D10
ICPC
Vomiting
2.3
6.0
51
248
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
34
8.24
18.96
21.8
22.7
1407.81
1436.29
nmol/l
0.04
26
34
143
767
2.57
14.95
4.8
3.3
28.29
31.54
u/l
0.90
137
720
149
833
2.48
14.04
9.3
8.8
1.22
1.22
mmol/l
0.00
141
778
114
570
2.56
13.56
1.9
1.5
94.32
97.74
pmol/l
0.40
59
297
154
912
2.34
12.32
9.5
8.9
1.22
1.22
mmol/l
0.17
137
807
86
394
2.62
12.08
2.2
2.2
156.44
391.72
u/l
0.77
81
376
128
706
2.36
12.01
6.2
6.2
37.88
38.35
g/l
0.40
117
664
92
439
2.54
11.86
2.3
1.6
1.51
1.37
%
2.54
83
404
111
581
2.40
11.67
3.5
3.7
8.14
8.94
mmol/l
0.70
98
528
52
191
3.06
10.99
1.7
1.5
1053.96
1021.16
nmol/l
0.11
45
149
71
322
2.55
10.03
1.6
1.3
16.30
19.44
nmol/l
1.43
65
284
34
103
3.58
9.75
1.5
1.3
—
—
—
0
0
211
1515
2.17
9.54
8.7
5.6
90.24
86.12
u/l
0.42
195
1418
142
883
2.10
9.37
7.5
5.6
9.87
11.14
umol/l
0.92
128
827
105
588
2.17
9.04
4.1
3.3
0.17
0.16
e6/l
0.07
77
438
46
178
2.85
8.81
6.7
9.8
105.15
104.99
mmol/l
0.09
46
178
246
1920
2.24
8.40
4.8
3.8
14.11
14.51
pmol/l
1.91
232
1757
117
699
2.07
8.40
4.1
3.5
—
—
—
0
0
176
1224
1.98
8.15
6.8
5.3
6.08
6.12
mmol/l
0.08
164
1086
41
161
2.78
7.62
6.5
9.9
1.24
1.34
mmol/l
0.30
41
151
65
322
2.28
7.41
10.5
8.6
1.19
1.21
mmol/l
0.16
59
311
139
915
1.92
7.35
3.9
2.8
67.00
68.28
nmol/l
0.20
130
855
97
564
2.04
7.35
3.1
2.6
2.37
2.38
mmol/l
0.13
89
514
68
345
2.24
7.32
3.2
3.1
0.82
0.55
e6/l
0.78
36
178
61
296
2.31
7.29
5.8
8.8
1.11
1.21
mmol/l
0.08
55
231
203
1518
1.93
7.22
18.3
9.3
3.86
3.78
e9/l
0.25
176
1305
235
1877
1.97
6.49
4.6
2.5
5.77
5.47
mmol/l
2.54
223
1728
208
1600
1.87
6.42
4.6
3.3
36.36
36.54
mmol/mol
0.09
203
1518
65
341
2.14
6.39
3.3
3.2
5.44
2.99
e6/l
0.83
33
176
54
265
2.25
6.25
5.5
4.3
5.13
8.48
umol/l
0.99
39
208
22
69
3.35
5.99
1.4
1.6
—
—
—
0
0
262
2204
2.07
5.83
5.7
4.2
1.87
1.81
mu/l
0.39
252
2076
207
1624
1.79
5.62
5.3
3.2
46.96
30.68
u/l
1.63
193
1563
289
2551
2.46
5.30
12.1
7.5
31.85
27.77
u/l
1.08
281
2457
88
546
1.85
5.29
4.3
2.6
51.69
55.64
u/l
0.54
78
503
178
1386
1.65
4.53
10.2
7.3
32.31
32.60
%
0.12
168
1334
41
205
2.15
4.52
2.8
2.8
29.00
30.32
u/l
0.12
35
174
14
33
4.39
4.37
9.9
7.8
5.02
4.95
kpa
0.16
14
33
15
38
4.09
4.36
1.3
1.5
—
—
—
0
0
48
261
1.99
4.24
1.6
1.5
483.48
28270477.65
pmol/l
0.50
42
237
227
1905
1.67
4.09
14.3
7.1
107.52
106.12
ml/min/173m2
0.36
176
1426
48
268
1.93
3.93
2.1
1.8
—
—
—
0
0
173
1369
1.58
3.89
10.1
7.1
51.92
53.23
%
0.75
163
1317
18
66
2.83
3.82
7.8
10.3
0.67
0.61
%
0.33
18
66
84
561
1.68
3.79
7.2
5.6
1.03
1.10
inr
1.35
38
213
231
1970
1.63
3.67
4.0
2.7
2.82
2.77
mmol/l
0.47
223
1866
15
51
3.04
3.62
3.6
5.5
62.75
49.05
%
1.06
15
51
80
536
1.66
3.55
3.4
2.5
1.02
1.02
kg/l
0.44
12
72
19
76
2.60
3.45
6.2
10.8
0.72
0.69
%
0.09
19
76
19
77
2.56
3.36
6.3
10.7
2.71
1.34
%
1.35
19
77
280
2536
1.87
3.31
16.0
9.5
21.07
21.12
mg/l
0.01
220
1813
19
78
2.53
3.28
6.4
10.7
90.11
94.68
%
0.70
19
78
217
1854
1.54
3.14
3.5
2.5
1.38
1.18
mmol/l
2.56
204
1754
11
30
3.76
3.11
5.7
2.0
17.16
17.93
%
—
5
16
47
282
1.78
3.08
11.9
11.7
24.53
25.07
mmol/l
0.58
47
282
47
285
1.76
2.98
4.6
2.6
79.89
1544.53
ng/l
1.44
18
126
83
585
1.57
2.95
2.7
2.9
2.78
2.52
mg/l
0.62
75
506
309
2945
2.74
2.94
27.7
14.0
268.22
262.40
e9/l
0.88
297
2857
309
2950
2.68
2.81
27.6
13.9
4.64
4.64
e12/l
0.01
297
2861
67
454
1.60
2.80
2.2
2.9
0.72
1.14
mg/l
0.94
45
301
309
2947
2.71
2.80
28.1
14.1
40.10
42.36
%
0.78
288
2826
34
192
1.86
2.71
1.8
1.6
—
—
—
0
0
8
19
4.29
2.69
1.5
1.4
—
—
—
0
0
65
444
1.58
2.63
3.6
2.3
15.44
18.20
ng/l
0.19
33
169
223
1950
1.48
2.61
3.7
2.6
1.29
1.40
mmol/l
4.59
212
1854
8
20
4.08
2.58
3.0
4.5
22.25
21.00
umol/l
—
8
20
34
196
1.82
2.55
1.9
1.6
—
—
—
0
0
35
205
1.79
2.50
2.0
1.8
5.03
7.01
u/l
1.11
27
151
19
90
2.18
2.44
1.9
1.6
—
—
—
0
0
223
1970
1.44
2.31
3.9
2.7
4.49
4.52
mmol/l
0.24
216
1876
7
18
3.95
2.26
1.6
1.9
11.14
9.69
umol/l
—
7
18
263
2408
1.53
2.19
24.9
12.5
14.10
13.47
%
1.38
258
2377
8
25
3.26
2.11
1.1
1.1
—
—
—
0
0
47
314
1.58
2.09
3.0
2.7
20228.27
3976.80
u/l
0.72
15
136
42
273
1.62
2.09
4.3
4.7
21.59
17.23
mg/mmol
0.12
25
202
6
15
4.06
2.05
1.0
1.0
2070.17
1556.47
miu/ml
—
6
15
27
156
1.80
2.04
1.7
1.8
—
—
—
0
0
11
44
2.55
2.03
1.1
1.4
407.00
384.49
ug/g
—
5
23
42
275
1.61
2.03
1.0
1.0
—
—
—
0
0
20
105
1.97
2.00
2.2
2.7
75.71
95.86
ml/min/173m2
—
7
37
27
157
1.79
2.00
4.6
2.2
—
—
—
0
0
7
21
3.38
1.97
1.3
1.4
—
—
—
0
0
7
21
3.38
1.97
1.3
1.3
—
—
—
0
0
43
286
1.58
1.95
3.0
4.1
29.46
30.31
s
0.70
43
279
30
183
1.71
1.90
2.1
1.9
4.65
10.79
iu/l
3.34
23
131
36
231
1.63
1.89
2.8
1.8
—
—
—
0
0
35
223
1.64
1.89
2.7
2.2
2.41
2.41
mmol/l
0.13
29
193
7
22
3.23
1.89
1.3
1.3
—
—
—
0
0
28
169
1.72
1.84
1.4
1.4
—
—
—
0
0
27
163
1.72
1.78
1.8
2.2
—
17.03
—
0
12
184
1613
1.33
1.75
4.7
3.8
9.81
7.22
mm/h
1.74
178
1502
8
30
2.71
1.73
2.1
2.9
881.50
790.93
e6/l
—
8
30
25
150
1.72
1.69
1.1
1.2
—
18.90
—
0
5
151
1293
1.32
1.67
3.7
3.1
74.18
62.68
ug/l
0.46
146
1208
116
959
1.33
1.63
1.5
1.5
0.38
2.34
u/ml
2.53
20
205
19
106
1.84
1.62
1.4
1.5
—
—
—
0
0
39
267
1.53
1.58
2.8
2.2
320.88
380.02
nmol/l
1.13
34
248
16
86
1.91
1.53
1.9
1.5
—
—
—
0
0
37
254
1.52
1.49
7.1
6.1
0.67
1.21
mmol/l
0.57
26
185
111
927
1.30
1.42
2.7
2.3
—
—
—
0
0
15
82
1.87
1.38
1.9
2.0
36.93
39.91
u/l
0.40
15
77
9
42
2.18
1.35
1.6
1.7
—
—
—
0
0
8
34
2.39
1.30
1.1
1.1
—
—
—
0
0
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
130
1121
1.27
1.28
4.3
2.9
0.00
0.00
estimate
-0.00
28
240
9
45
2.03
1.24
3.3
4.6
6.98
7.28
u/ml
—
9
45
20
124
1.65
1.24
2.0
1.7
—
—
—
0
0
8
37
2.19
1.22
2.8
2.9
8.62
10.11
%
—
8
37
5
19
2.66
1.22
1.4
3.1
—
—
—
0
0
5
19
2.66
1.22
1.4
3.1
—
—
—
0
0
19
295
0.62
1.20
1.2
1.3
—
—
—
0
0
76
617
1.30
1.19
2.7
2.1
—
—
—
0
0
5
20
2.52
1.15
1.0
1.0
—
—
—
0
0
117
1007
1.26
1.15
3.1
2.8
—
—
—
0
0
7
30
2.36
1.13
1.3
1.5
—
—
—
0
0
7
30
2.36
1.13
4.0
1.7
—
—
—
0
0
7
31
2.29
1.11
1.7
1.8
—
—
—
0
0
7
31
2.29
1.11
1.4
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
44
335
1.36
1.06
1.5
1.2
9.00
13.30
iu/ml
—
9
83
21
138
1.56
1.06
1.3
1.6
—
—
—
0
0
23
155
1.52
1.04
1.7
1.4
—
—
—
0
0
5
22
2.29
1.03
1.0
1.5
—
—
—
0
0
5
22
2.29
1.03
1.4
1.5
—
—
—
0
0
10
53
1.92
1.02
1.7
1.7
—
—
—
0
0
10
53
1.92
1.02
2.1
1.7
—
—
—
0
0
33
241
1.41
1.02
1.6
1.2
—
—
—
0
0
7
35
2.02
1.00
1.4
1.2
—
—
—
0
0
127
1117
1.23
1.00
6.2
4.1
0.00
0.00
estimate
-0.00
28
246
7
36
1.97
0.97
2.6
2.9
—
—
—
0
0
29
209
1.43
0.96
3.2
3.6
1239.87
411.00
ng/l
0.39
22
160
128
1131
1.22
0.96
4.4
2.9
0.00
0.00
estimate
-0.00
28
235
115
1007
1.22
0.94
3.1
2.4
—
—
—
0
0
25
176
1.46
0.94
5.4
3.4
4.74
5.06
pmol/l
0.89
20
163
6
29
2.09
0.90
1.0
1.0
—
—
—
0
0
20
136
1.50
0.89
1.3
1.6
197.00
181.24
u/ml
0.16
12
71
8
43
1.88
0.88
1.1
1.3
—
—
—
0
0
10
57
1.78
0.84
1.2
1.1
—
—
—
0
0
10
57
1.78
0.84
1.2
1.1
—
—
—
0
0
35
450
0.75
0.84
1.7
1.5
—
—
—
0
0
13
201
0.63
0.84
1.9
1.6
—
—
—
0
0
11
65
1.72
0.83
2.5
2.2
—
—
—
0
0
8
46
1.76
0.83
3.3
2.2
124.38
135.82
g/l
—
8
38
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
6
32
1.89
0.82
1.2
1.7
—
—
—
0
0
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
20
139
1.47
0.81
3.4
5.2
87.40
94.76
%
0.61
20
139
12
185
0.63
0.78
2.0
2.0
—
—
—
0
0
35
442
0.77
0.75
1.5
1.5
—
—
—
0
0
9
54
1.69
0.75
4.7
4.8
59.78
53.85
%
—
9
54
252
2621
0.81
0.74
4.4
4.1
—
—
—
0
0
7
38
1.86
0.74
2.0
2.9
0.20
0.20
e9/l
—
7
27
61
513
1.23
0.73
2.7
2.0
—
—
—
0
0
19
134
1.44
0.73
8.2
3.7
—
—
—
0
0
5
25
2.02
0.73
1.4
1.4
—
—
—
0
0
7
39
1.81
0.73
1.0
1.3
—
—
—
0
0
7
40
1.77
0.71
2.0
2.9
512.71
510.89
e6/l
—
7
28
5
26
1.94
0.71
1.4
1.4
—
—
—
0
0
13
86
1.53
0.67
1.2
1.1
—
—
—
0
0
5
28
1.80
0.66
1.4
1.1
—
—
—
0
0
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
32
252
1.30
0.66
1.2
1.3
111.00
154.61
iu/ml
0.21
11
94
5
30
1.68
0.61
1.2
1.2
—
—
—
0
0
8
52
1.55
0.60
2.0
1.5
—
—
—
0
0
67
583
1.19
0.58
4.2
3.1
0.00
0.00
estimate
0.50
26
238
6
36
1.68
0.57
1.3
2.4
—
—
—
0
0
19
142
1.36
0.56
1.0
1.2
1.09
6.43
u/ml
3.21
12
105
9
61
1.49
0.54
2.2
2.1
—
—
—
0
0
9
62
1.46
0.53
3.0
3.3
0.56
0.55
nmol/l
—
9
53
6
39
1.55
0.53
2.0
1.7
—
—
—
0
0
6
39
1.55
0.53
2.0
1.7
—
—
—
0
0
9
133
0.67
0.53
1.0
1.2
—
—
—
0
0
16
213
0.74
0.52
1.6
1.6
—
—
—
0
0
20
155
1.31
0.48
1.0
1.2
0.26
4.27
u/ml
3.66
12
107
7
47
1.50
0.48
2.4
1.9
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
106.27
—
0
15
5
36
1.39
0.38
2.2
1.4
—
—
—
0
0
9
69
1.31
0.37
1.1
2.1
—
—
—
0
0
18
144
1.26
0.36
1.0
1.1
6.96
2.51
u/ml
0.34
11
98
20
243
0.81
0.35
1.3
1.5
—
—
—
0
0
18
219
0.81
0.32
1.2
1.4
—
—
—
0
0
89
827
1.11
0.31
4.1
2.8
—
—
—
0
0
7
54
1.30
0.30
2.1
1.5
—
—
—
0
0
8
106
0.75
0.29
1.0
1.1
—
7.89
—
0
19
22
187
1.19
0.27
1.2
1.4
215.16
283.18
miu/ml
—
5
96
8
66
1.22
0.27
1.0
1.1
—
139.56
—
0
25
9
73
1.24
0.25
1.4
1.2
—
—
—
0
0
15
178
0.83
0.22
1.5
1.5
—
—
—
0
0
19
220
0.85
0.22
1.2
1.4
—
—
—
0
0
19
220
0.85
0.22
1.2
1.4
—
—
—
0
0
55
509
1.10
0.22
3.1
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
81.47
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
5
43
1.17
0.21
1.2
1.2
—
—
—
0
0
36
327
1.11
0.20
1.5
1.2
4.13
5.49
u/ml
—
9
136
9
111
0.81
0.20
1.4
1.4
5.40
3.56
ug/l
—
9
103
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
78
0.76
0.15
1.0
1.1
—
—
—
0
0
27
296
0.90
0.15
1.4
1.4
—
—
—
0
0
9
81
1.11
0.15
1.6
1.1
—
—
—
0
0
11
129
0.85
0.15
1.5
1.3
—
—
—
0
0
9
83
1.09
0.15
1.6
1.1
—
—
—
0
0
8
97
0.82
0.14
2.3
1.6
1.18
1.19
g/l
—
8
92
117
1142
1.04
0.10
2.3
1.9
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
5
65
0.77
0.08
1.2
1.7
—
—
—
0
0
7
81
0.86
0.07
1.6
1.3
—
—
—
0
0
9
105
0.85
0.06
1.7
1.8
—
—
—
0
0
21
220
0.95
0.03
1.2
1.4
—
—
—
0
0
13
128
1.02
0.00
1.3
1.8
6.08
3.11
mg/l
—
8
78
0
9
0.00
0.00
0.0
1.1
—
9.98
—
0
9
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
15.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.7
—
32.50
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
33.86
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
34.50
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_CHILDSOC – Social disorders starting during childhood or adolescence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).